Legenda : Ensaio em fase de recrutamento = 
; Ensaio a decorrer = 
-
- ALEMANHA
- Baden-Württemberg
- ULM
- Phase II Study of pioglitazone in patients with amyotrophic lateral sclerosis - Terminated
- Universitätsklinikum Ulm
- Klinik für Neurologie
- Mais detalhes
-
- ALEMANHA
- Baden-Württemberg
- ULM
- MITOTARGET : Phase II/III, multicenter, randomized, parallel group, double-blind, placebo controlled study to assess safety and efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) patients treated with Riluzole - Terminated
- Universitätsklinikum Ulm
- Klinik für Neurologie
- Mais detalhes
-
- ALEMANHA
- Baden-Württemberg
- ULM
- EMPOWER - A randomized, double-blind, placebo-controlled, multicentre phase III study of the safety and efficacy of Dexpramipexole in subjects with Amyotrophic Lateral Sclerosis - DE
- Universitätsklinikum Ulm
- Klinik für Neurologie
- Mais detalhes
-
- ANA-ALS01: Open safety and tolerability phase II trial to evaluate a subcutaneous injection solution of 100 mg of Anakinra in combination with Riluzol in patients with Amyotrophic Lateral Sclerosis
- Charité - Universitätsmedizin Berlin (CVK)
- Klinik für Neurologie (CVK)
- Mais detalhes
-
- OLN-ALS01: Randomized, placebo-controlled parallel group study for the evaluation of an oral dose of 10mg Olanzapine in combination with Riluzole for the treatment of loss of appetite in patients with Amyotrophic Lateral Sclerosis (Phase II/III) - Terminated
- Charité - Universitätsmedizin Berlin (CVK)
- Klinik für Neurologie (CVK)
- Mais detalhes
-
- EMPOWER - A randomized, double-blind, placebo-controlled, multicentre phase III study of the safety and efficacy of Dexpramipexole in subjects with Amyotrophic Lateral Sclerosis - DE
- Charité - Universitätsmedizin Berlin (CVK)
- Klinik für Neurologie (CVK)
- Mais detalhes
-
- An open-label safety extension study of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) patients treated with Riluzole (Phase II/III) - Terminated
- Charité - Universitätsmedizin Berlin (CVK)
- Klinik für Neurologie (CVK)
- Mais detalhes
-
- ALEMANHA
- Berlin
- NOT YET IDENTIFIED - DE
- NOG112264: A phase II study of Ozanezumab (GSK1223249) versus placebo in the treatment of Amyotrophic Lateral Sclerosis - DE
- Not yet identified - DE
- Mais detalhes
-
- ALEMANHA
- Nordrhein-Westfalen
- BIELEFELD
- Influence of G-CSF(granulocyte colony-stimulating factor) and EPO(Erythropoietin) on associative learning and motor skills (Phase II) - Terminated
- Evangelisches Krankenhaus Bielefeld - Standort Bethel
- Klinik für Neurologie
- Mais detalhes
-
- BELGICA
- VLAAMS BRABANT
- LEUVEN
- Phase II/III, Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole.
- University Hospitals Leuven - Gasthuisberg
- NMRC UZLeuven
- Mais detalhes
-
- BELGICA
- VLAAMS BRABANT
- LEUVEN
- A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis (Phase I-II).
- University Hospitals Leuven - Gasthuisberg
- NMRC UZLeuven
- Mais detalhes
-
- ESPANHA
- Comunidad Valenciana
- SANT JOAN D'ALACANT
- Phase I/II Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (completed)
- Instituto de Neurociencias de Alicante (CSIC-UMH)
- Unidad de Neurobiología del Desarrollo
- Mais detalhes
-
- ESPANHA
- Comunidad Valenciana
- SANT JOAN D'ALACANT
- Extension CMN/ELA: Phase I/II Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis
- Instituto de Neurociencias de Alicante (CSIC-UMH)
- Unidad de Neurobiología del Desarrollo
- Mais detalhes
-
- A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of Talampanel in Subjects With Amyotrophic Lateral Sclerosis (ALS) (Phase II) (completed)
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- Mais detalhes
-
- Phase II/III, Multicenter, Randomized, Parallel Group, Double-blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole (MITOTARGET) (completed)
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- Mais detalhes
-
- An Open-label Safety Extension Study of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole (Phase II-III) - ES (completed)
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- Mais detalhes
-
- EMPOWER - A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis (Phase III)
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- Mais detalhes
-
- ENVISION - An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis (Phase III) - ES
- Hospital Carlos III
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- Mais detalhes
-
- Randomized clinical trial double blind of litium carbonate as association therapy in amyotrophic lateral sclerosis (Phase II) (terminated)
- Hospital Universitario 12 de Octubre
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- Mais detalhes
-
- Memantine (Ebixa) for functional disability in amyotrophic lateral sclerosis (Phase IV)
- Hospital Universitario 12 de Octubre
- Unidad de ELA (Esclerosis Lateral Amiotrófica)
- Mais detalhes
-
- Phase I/II Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (completed)
- Hospital Universitario Virgen de la Arrixaca
- Unidad de trasplante hematopoyético y terapia celular
- Mais detalhes
-
- Extension CMN/ELA: Phase I/II Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis
- Hospital Universitario Virgen de la Arrixaca
- Unidad de trasplante hematopoyético y terapia celular
- Mais detalhes
-
- FRANCA
- ILE-DE-FRANCE
- PARIS
- Nemucough : Evaluation of a Mechanical Insufflation-Exsufflation Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders: a Prospective, Randomized, Controlled, Multicenter Study (Phase III)
- CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
- Service de pneumologie pédiatrique
- Mais detalhes
-
- FRANCA
- ILE-DE-FRANCE
- PARIS
- An Open-Label Safety Extension Study of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) patients treated with riluzole - FR
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Groupement hospitalier universitaire Pitié-Salpétrière
- Mais detalhes
-
- FRANCA
- ILE-DE-FRANCE
- PARIS
- Phase II/III, Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole (MITOTARGET)
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Fédération des maladies du système nerveux
- Mais detalhes
-
- FRANCA
- ILE-DE-FRANCE
- PARIS
- LISLA : A Phase II Open Multicenter Study of Lithium in Patients With Amyotrophic Lateral Sclerosis
- CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
- Département à la Recherche Clinique et Développement
- Mais detalhes
-
- FRANCA
- RHONE-ALPES
- NOT YET IDENTIFIED - FR
- DOSERALS: Etude des transporteurs de la dopamine et de la sérotonine en imagerie TEMP utilisant les radiopharmaceutiques 123I-FP-CIT (datscan) and 123 I-ADAM dans la sclérose latérale amyotrophique et dans une population contrôle - FR
- Not yet identified - FR
- Mais detalhes
-
- Efficacy safety and tolerability of growth hormone in patients with amyotrophic lateral sclerosis as add-on therapy to Riluzole-Phase II
- Azienda Ospedaliera Universitaria "Federico II"
- Dipartimento di Scienze Neurologiche
- Mais detalhes
-
- PAISES BAIXOS
- Noord-Holland
- AMSTERDAM
- Earlier PEG tube placement in ALS patients with dysphagia: effects on survival, nutritional and functional status, and quality of life - an intervention study
- AMC - Academisch Medisch Centrum
- Afdeling Neurologie
- Mais detalhes
-
- PAISES BAIXOS
- Utrecht
- UTRECHT
- Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Polikliniek Neurologie en Neurochirurgie
- Mais detalhes
-
- PAISES BAIXOS
- Utrecht
- UTRECHT
- A randomised sequential trial of Lithium in amyotrophic lateral sclerosis
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Polikliniek Neurologie en Neurochirurgie
- Mais detalhes
-
- Ensaio Clínico da Memantina no Tratamento da Incapacidade da Esclerose Lateral Amiotrófica (Phase II-III) - Terminated -
- Hospital de Sta. Maria
- Faculdade de Medicina de Lisboa
- Mais detalhes
